Table 3.
Changes in plasma eicosapentaenoic acid (EPA) levels in hypertriglyceridemic subjects after 8-week EPA supplementation stratified by Leu162 and Val162 peroxisome proliferator-activated receptor alpha genotypes*
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.